PHILADELPHIA, May 21 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy, announced today the appointment of Susan Driscoll to the position of President and CEO of Wolters Kluwer Health, Professional & Education effective June 1, 2010. Ms. Driscoll is currently Executive Vice President & General Manager, Professional & Education.
Ms. Driscoll has 30 years of experience in academic and trade publishing. In her past two years with Wolters Kluwer Health as Executive Vice President & General Manager, Professional & Education, she has successfully led the transformation of the Professional & Education sales, marketing and editorial functions to an electronic orientation.
"Susan brings strong publishing leadership skills and a track record of successful execution to this role," according to Bob Becker, President & CEO of Wolters Kluwer Health & Pharma Solutions. "Susan has been instrumental in the successful transformation of Professional & Education from a traditional publisher to a world-class content and solutions provider. Wolters Kluwer Health and its Lippincott Williams & Wilkins brand will greatly benefit from Susan's leadership."
Prior to joining Wolters Kluwer Health, Ms. Driscoll was Vice President, Strategy for Author Solutions, Inc., a technology-driven print-on-demand and publishing solutions provider. Prior to the purchase of iUniverse, Inc. by Author Solutions in 2007, Ms. Driscoll served as President/CEO of iUniverse, where she successfully implemented a company turnaround and built the iUniverse brand as a respected alternative to traditional publishing.
Ms. Driscoll also served as Chief Operating Officer of Bedford, Freeman & Worth (part of Holtzbrinck Publishers Holdings), where she guided operations and new media strategy for the college textbook publisher. She has held senior management roles at HarperCollins and Holt, Rinehart & Winston. She holds a Bachelor of Fine Arts degree from the University of Notre Dame, and currently serves on the Advisory Council to the Snite Museum of Art at Notre Dame. In 2009, Ms. Driscoll was named as one of the top fifty women in publishing by Book Business magazine.
Ms. Driscoll succeeds Gordon Macomber, current President and CEO Wolters Kluwer Health, Professional & Education, and will report directly into Mr. Becker.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2009 annual revenues of euro 3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
This press release contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE Wolters Kluwer Health
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All